Neurogenetische testen marktomvang, aandelen, groei en industrieanalyse, per type (exome sequencing, hele genoomsequencing, RNA -sequencing, algemene DNA -testen), per toepassing (ziekenhuizen, speciale klinieken, onderzoeksinstituten en diagnostische laboratoria) en regionale voorspelling tot 2033

Gedetailleerde TOC van Global Neurogenetic Testing Market Research Report 2024 (Status and Outlook)

Inhoudstabel
1 Onderzoeksmethodologie en statistische scope
1.1 Marktdefinitie en statistische reikwijdte van neurogenetische testen
1.2 Belangrijkste marktsegmenten
1.2.1 Neurogenetische testsegment door type
1.2.2 Neurogenetische testsegment door toepassing
1.3 -methode van informatie 1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurogenetic Testing Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurogenetic Testing Market Competitive Landscape
3.1 Global Neurogenetic Testing Revenue Market Share by Company (2019-2024)
3.2 Neurogenetisch testmarktaandeel per bedrijfstype (Tier 1, Tier 2 en Tier 3)
3.3 Bedrijf Neurogenetische testen Marktgrootte Sites, Geserveerd gebied, Producttype
3,4 Neurogenetische test Markt Concurrerende situatie en trends
3.4.1 Neurogenetische testconcentratie Marktconcentratie 4 Neurogenetic Testing Value Chain Analysis
4.1 Neurogenetic Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Neurogenetic Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Uitbreidingen
5.5.3 Samenwerking/leveringscontracten
5.6 Industriebeleid
6 Neurogenetische testmarktsegmentatie per type
6.1 Evaluatiematrix van segment marktontwikkelingspotentieel (type)
6.2 Global neurogenetische testmarkt Markt Grootte marktaandeel BIJ TYPE TYPE (2019-2024)
6.BR> 6024)
6024) (2019-2024)
7 Neurogenetische testmarktsegmentatie door toepassing
7.1 evaluatiematrix van segmentmarktontwikkelingspotentieel (applicatie)
7.2 Global Neurogenetic Testing Market Grootte (M USD) per toepassing (2019-2024)
7.3 Global neurogenetische testen Grootte groeipercentage per toepassing (2019-2024)
8-24)
8-24)
8-24) Neurogenetische testmarktgrootte per regio
8.1.1 Wereldwijde marktomvang van neurogenetische tests per regio
8.1.2 Wereldwijde marktaandeel van de markt voor neurogenetische tests markt voor regio
8.2 Noord -Amerika
8.2.1 Noord -Amerika Neurogenetische testmarkt Grootte per land
8.2.2 U.S. 8.2.3. Land
8.3.2 Duitsland
8.3.3 Frankrijk
8.3.4 U.K.
8.3.5 Italië
8.3.6 Rusland
8.4 Asia Pacific
8.4.1 Asia Pacific Neurogenetic Testing Market Grootte door regio
8.4.2 China
8.4 South Korea
America
8.5.1 South America Neurogenetic Testing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurogenetic Testing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Quest Diagnostics
9.1.1 Quest Diagnostics Neurogenetic Testing Basic Information
9.1.2 Quest Diagnostics Neurogenetic Testing Product Overview
9.1.3 Quest Diagnostics Neurogenetic Testing Product Market Performance
9.1.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.1.5 Quest Diagnostics Business Overview
9.1.6 Quest Diagnostics Recent Developments
9.2 Mayo Clinic
9.2.1 Mayo Clinic Neurogenetic Testing Basic Information
9.2.2 Mayo Clinic Neurogenetic Testing Product Overview
9.2.3 Mayo Clinic Neurogenetic Testing Product Market Performance
9.2.4 Quest Diagnostics Neurogenetic Testing SWOT Analysis
9.2.5 Mayo Kliniek Bedrijfsoverzicht
9.2.6 Mayo Clinic Recente ontwikkelingen
9.3 Genedx
9.3.1 Genedx Neurogenetic Testing Basisinformatie
9.3.2 Genedx Neurogenetic Testing Productoverzicht
9.3.3 Genedx Neurogenetic Test Product Marktprestaties
9.3.4 Quest Diagnostics Neurogenetic Swot Swot Analysis
9.3.5 GENEDX BEDRIJF BEDRIJFSEN
9.3.4 QUISSE TESTEN SWOTS SWOTS -analyse
9.3.5 GENEEDX BEDRIJF BEDRIJFS
9.4 Overview
9.3.6 GeneDx Recent Developments
9.4 Illumina
9.4.1 Illumina Neurogenetic Testing Basic Information
9.4.2 Illumina Neurogenetic Testing Product Overview
9.4.3 Illumina Neurogenetic Testing Product Market Performance
9.4.4 Illumina Business Overview
9.4.5 Illumina Recent Developments
9.5 Labcorp
9.5.1 labcorp neurogenetische tests basisinformatie
9.5.2 labcorp neurogenetische testproductoverzicht
9.5.3 labcorp neurogenetische testen productmarktprestaties
9.5.4 labcorp business overzicht
9.5.5 labcorp recente ontwikkelingen
9.6 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae
9.6.1 Invitae Basic. Informatie
9.6.2 Invitae Neurogenetic Testing Productoverzicht
9.6.3 Invitae Neurogenetic Test Product Marktprestaties
9.6.4 Invitae Business Overzicht
9.6.5 Invitae Recente ontwikkelingen
9.7 MedGenome Labs
9.7.1 MedGenome Labs NeuroSetic Information
9.7.2 Medgenetic -laboratorium Labs Neurogenetic Informatie
9.7.2 Medgenetische laboratoria Neurogenetic Informatie
9.7.2 MedGeSetic -laboratorium Labs Neurogenetic Informatie
9.7.2 Medgenetische laboratorium. Productoverzicht
9.7.3 MedGenome Labs Neurogenetic Testing Product Marktprestaties
9.7.4 MedGenome Labs Business Overzicht
9.7.5 MedGenome Labs Recente ontwikkelingen
9.8 Connecticut Children's
9.8.1 Connecticut Children's Neurogenetic Testing Basis
9.8.2 Connecticut Children's Neurogenetic Product Product Product Product van kinderen Overview
9.8.3 Connecticut Children’s Neurogenetic Testing Product Market Performance
9.8.4 Connecticut Children’s Business Overview
9.8.5 Connecticut Children’s Recent Developments
9.9 CENTOGENE
9.9.1 CENTOGENE Neurogenetic Testing Basic Information
9.9.2 CENTOGENE Neurogenetic Testing Product Overview
9.9.3 CENTOGENE Neurogenetic Testing Product Market Performance
9.9.4 CENTOGENE Business Overview
9.9.5 CENTOGENE Recent Developments
9.10 Victorian Clinical Genetics Services
9.10.1 Victorian Clinical Genetics Services Neurogenetic Testing Basic Information
9.10.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Overview
9.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Product Market Prestaties
9.10.4 Victorian Clinical Genetics Services Business Overzicht
9.10.5 Victorian Clinical Genetics Services Recente ontwikkelingen
9.11 Pacbio
9.11.1 Pacbio Neurogenetic Test Basisinformatie
9.11.2 Pacbio Neurogenetic Testing Product Overview
9.11.3 Pacbio Test Productmarktprestaties
9.11.4 Pacbio Pacbio Pacbio Pacbio Product overview
9.11.3 Pacbio Test Productmarktprestaties
9.11.4 PacBio Business Overview
9.11.5 PacBio Recent Developments
10 Neurogenetic Testing Regional Market Forecast
10.1 Global Neurogenetic Testing Market Size Forecast
10.2 Global Neurogenetic Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurogenetic Testing Market Size Forecast by Country
10.2.3 Asia Pacific Neurogenetic Testing Market Size Forecast by Regio
10.2.4 Zuid-Amerika Neurogenetische testen Marktgrootte Voorspelling per land
10.2.5 Midden-Oosten en Afrika voorspelde consumptie van neurogenetische testen door land
11 Voorspellingsmarkt per type en per toepassing (2024-2031)
11.1 Global neurogenetische testmarkt voorspelling door type (2024-2031 (2024-2031)
12 Conclusie en belangrijke bevindingen